Services
Clinical Trial Services in Serbia Tailored to Your Needs
From Study Startup to Monitoring, We Deliver Success
Clinical trials require experience, deep regulatory knowledge, and the flexibility to adapt to each
project`s unique needs.
When you partner with EBS CRO, you`re working with a seasoned team backed
by 20+ years of hands-on experience in planning, managing, and delivering high-quality clinical research
in Serbia.
We’ve supported a wide range of trials—across both medical devices and investigational drugs—and we
understand what it takes to meet both local and international standards.
With EBS, you`re not just getting a service provider; you`re gaining a reliable partner who knows how to get your trial done right.
Our Services include:
EBS CRO can utilize its wide local network to identify top-performing clinical sites and experienced
PIs with proven track records in the same or similar therapeutic areas. Feasibility assessments in
Serbia include evaluating patient availability, site infrastructure, and previous audit/inspection
outcomes, ensuring efficient recruitment and regulatory compliance from the start.
Serbian regulations require alignment with both global and local clinical trial requirements. EBS CRO
provides expert review of Informed Consent Forms and other documents to ensure compliance with
local regulations, helping sponsors avoid costly delays.
Import of IMPs and medical devices in Serbia requires permits from authorities. EBS CRO facilitates
the complete process by working closely by both official importer/exporter and global study team.
EBS CRO offers full project management tailored to Serbia’s clinical research environment. This
includes real-time communication with sites, issue resolution, site monitoring, and quality control
measures aligned with ICH-GCP. Local CRAs ensure cultural fluency and regulatory familiarity,
enhancing study oversight and data integrity.
EBS CRO provides structured, timely reporting in accordance with local requirements in compliance
with Serbian law. The CRO also compiles and submits quarterly study progress reports that include
the number of patients enrolled, their current statuses (e.g., screened, randomized, ongoing,
completed, withdrawn), as well as site activity summaries and safety updates. This supports
transparent communication and ongoing regulatory oversight throughout the study.